Suzhou Industrial Park Heshun Electric
300141
Guangdong Xiongsu Technology Group
300599
Sichuan Chuanhuan Technology
300547
Shanghai Wisdom Information Technology
301315
KANGNONG SEED
837403
CN Stock MarketDetailed Quotes
603983 Guangdong Marubi Biotechnology
- 33.82
- -0.71-2.06%
Market Closed Dec 27 15:00 CST
13.56BMarket Cap41.80P/E (TTM)
34.48High33.60Low23.59KlotVolume34.03Open34.53Pre Close80.30MTurnover0.59%Turnover Ratio52.27P/E (Static)401.00MShares36.8252wk High4.14P/B13.56BFloat Cap19.9252wk Low37.98Limit Up401.00MShs Float90.94Historical High31.08Limit Down2.55%Amplitude17.89Historical Low0.77Dividend TTM34.04Avg Price12.46KlotAsk2.28%Div YieldTTM100Lot Size9.35KlotBid
Guangdong Marubi Biotechnology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 27.07%1.95B | 27.65%1.35B | 38.73%661.39M | 28.52%2.23B | 34.34%1.54B | 29.64%1.06B | 24.58%476.75M | -3.10%1.73B | 0.53%1.14B | -6.48%817.18M |
| Operating revenue | 27.07%1.95B | 27.65%1.35B | 38.73%661.39M | 28.52%2.23B | 34.34%1.54B | 29.64%1.06B | 24.58%476.75M | -3.10%1.73B | 0.53%1.14B | -6.48%817.18M |
| Other operating revenue | ---- | 281.37%1.19M | ---- | -65.23%660.26K | ---- | -80.63%310.84K | ---- | -96.87%1.9M | ---- | -19.34%1.6M |
| Total operating cost | 23.97%1.7B | 25.64%1.15B | 39.32%539.83M | 29.33%2.03B | 33.24%1.37B | 31.20%911.65M | 24.73%387.47M | 3.08%1.57B | 2.87%1.03B | 1.91%694.87M |
| Operating cost | 10.57%495.34M | 8.19%342.43M | 12.47%167.95M | 19.17%652.22M | 22.31%447.97M | 25.78%316.51M | 17.21%149.33M | -14.89%547.29M | -14.18%366.25M | -19.86%251.64M |
| Operating tax surcharges | -8.65%15.66M | -15.34%10.79M | 9.02%5.73M | -9.17%22.5M | 1.23%17.14M | 5.19%12.74M | 5.58%5.25M | 5.37%24.78M | 11.26%16.93M | 17.54%12.11M |
| Operating expense | 34.62%1.07B | 39.70%717.49M | 64.10%332.65M | 41.65%1.2B | 48.78%795.5M | 42.50%513.59M | 41.28%202.71M | 14.15%846.16M | 10.59%534.68M | 14.30%360.41M |
| Administration expense | -2.66%71.25M | -1.81%46.47M | 0.31%20.81M | -2.14%108.89M | -7.52%73.19M | -8.56%47.33M | -16.04%20.75M | 10.87%111.27M | 14.52%79.14M | 22.54%51.76M |
| Financial expense | -17.13%-12.57M | -1.69%-7.66M | 9.18%-3.56M | -13.77%-14.39M | -31.69%-10.73M | -32.26%-7.53M | -26.24%-3.92M | 64.69%-12.65M | 76.95%-8.15M | 76.87%-5.69M |
| -Interest expense (Financial expense) | -26.93%4M | -18.73%2.53M | 15.09%1.52M | 104.54%6.63M | 136.66%5.47M | 310.48%3.12M | --1.32M | 216.49%3.24M | 247.96%2.31M | 51.34%759.59K |
| -Interest Income (Financial expense) | -5.02%-16.96M | 3.73%-10.7M | 1.28%-5.36M | -32.91%-21.41M | -43.42%-16.15M | -57.72%-11.11M | -46.32%-5.43M | 54.58%-16.11M | 67.73%-11.26M | 71.49%-7.05M |
| Research and development | 23.08%54.44M | 23.62%35.85M | 21.70%16.25M | 17.69%62.29M | 18.56%44.23M | 17.67%29M | 1.24%13.36M | 4.83%52.93M | -2.72%37.31M | 0.15%24.64M |
| Credit Impairment Loss | -114.88%-340.92K | -143.90%-726.23K | -697.84%-3.82M | 213.52%2.42M | 226.30%2.29M | 872.77%1.65M | 456.64%638.83K | -61.10%-2.14M | 645.80%702.33K | 44.15%-214.08K |
| Asset Impairment Loss | 27.07%-5.87M | -0.46%-5.59M | 18.39%-2.24M | -33.84%-13.05M | 0.42%-8.04M | -18.04%-5.57M | -37.88%-2.75M | 14.93%-9.75M | -11.49%-8.08M | 15.24%-4.72M |
| Other net revenue | 12.69%24.83M | 11.59%17.72M | 10.21%8.11M | 172.87%123.86M | -27.37%22.04M | 2.93%15.88M | 1.79%7.36M | 30.27%45.39M | 61.59%30.34M | -19.49%15.43M |
| Fair value change income | 81.76%865.06K | 131.31%599.49K | 232.80%148.99K | 1,240.98%70.98M | -87.76%475.95K | -89.58%259.18K | -96.15%44.77K | 766.23%5.29M | -63.38%3.89M | -66.63%2.49M |
| Invest income | -13.62%17.55M | -6.16%12.9M | -17.95%6.47M | 58.55%43.64M | -24.38%20.32M | -10.61%13.75M | 9.70%7.88M | 11.58%27.52M | 844.96%26.87M | 1,359.45%15.38M |
| -Including: Investment income associates | ---- | ---- | ---- | -3.51%-1.43M | ---- | ---- | ---- | -21.85%-1.38M | ---- | ---- |
| Asset deal income | -2,503.89%-206.14K | -89.60%892.04 | -89.60%892.04 | 66.65%514.57K | -22.95%8.58K | -22.95%8.58K | -22.95%8.58K | -26.75%308.77K | -72.38%11.13K | --11.13K |
| Other revenue | 83.68%12.83M | 82.45%10.54M | 392.47%7.56M | -19.90%19.34M | 0.58%6.99M | 133.20%5.78M | 46.95%1.53M | 10.13%24.15M | -63.63%6.95M | -86.88%2.48M |
| Operating profit | 47.57%282.14M | 37.28%224.65M | 34.19%129.68M | 54.02%319.34M | 29.29%191.18M | 18.81%163.64M | 21.94%96.64M | -30.65%207.34M | -6.96%147.88M | -34.75%137.73M |
| Add:Non operating Income | -17.54%180.61K | -62.06%50.27K | 35.87%33.04K | -50.14%242.64K | -51.01%219.04K | -69.75%132.47K | 689.73%24.31K | -96.01%486.65K | -96.22%447.14K | -96.29%437.93K |
| Less:Non operating expense | -73.21%159.23K | -93.32%38.67K | -95.64%19.43K | 100.74%2.49M | -44.36%594.39K | 7.70%578.66K | 32,085.68%445.62K | -21.01%1.24M | -30.57%1.07M | -50.66%537.28K |
| Total profit | 47.88%282.16M | 37.66%224.66M | 34.79%129.69M | 53.49%317.09M | 29.58%190.81M | 18.57%163.2M | 21.41%96.22M | -33.28%206.58M | -12.98%147.25M | -37.95%137.63M |
| Less:Income tax cost | 160.08%42.37M | 49.58%47.63M | 9.94%19.07M | 0.88%39.5M | -49.36%16.29M | 32.94%31.84M | 14.87%17.34M | -42.79%39.15M | -0.96%32.17M | -33.75%23.95M |
| Net profit | 37.40%239.79M | 34.77%177.03M | 40.25%110.62M | 65.79%277.59M | 51.64%174.52M | 15.55%131.35M | 22.94%78.88M | -30.58%167.43M | -15.84%115.09M | -38.77%113.68M |
| Net profit from continuing operation | 37.40%239.79M | 34.77%177.03M | 40.25%110.62M | 65.79%277.59M | 51.64%174.52M | 15.55%131.35M | 22.94%78.88M | -30.58%167.43M | -15.84%115.09M | -38.77%113.68M |
| Less:Minority Profit | 43.06%985.42K | -26.57%490.93K | -102.18%-4.49K | 369.12%18.17M | 113.99%688.84K | 119.74%668.53K | 115.56%205.4K | -0.34%-6.75M | 6.38%-4.92M | 2.60%-3.39M |
| Net profit of parent company owners | 37.38%238.8M | 35.09%176.54M | 40.62%110.63M | 48.93%259.42M | 44.84%173.83M | 11.63%130.68M | 20.15%78.67M | -29.74%174.18M | -15.49%120.01M | -38.11%117.07M |
| Earning per share | ||||||||||
| Basic earning per share | 39.53%0.6 | 33.33%0.44 | 40.00%0.28 | 51.16%0.65 | 43.33%0.43 | 13.79%0.33 | 25.00%0.2 | -30.65%0.43 | -14.29%0.3 | -38.30%0.29 |
| Diluted earning per share | 39.53%0.6 | 33.33%0.44 | 40.00%0.28 | 51.16%0.65 | 43.33%0.43 | 13.79%0.33 | 25.00%0.2 | -30.65%0.43 | -14.29%0.3 | -38.30%0.29 |
| Other composite income | -531.06%-53.32K | -121.79%-12.12K | -56.58%-22.64K | 55.82%-94.69K | 546.46%12.37K | 142.75%55.63K | 93.08%-14.46K | 78.76%-214.34K | -108.90%-2.77K | -277.48%-130.14K |
| Other composite income of parent company owners | -531.06%-53.32K | -121.79%-12.12K | -56.58%-22.64K | 55.82%-94.69K | 546.46%12.37K | 142.75%55.63K | 93.08%-14.46K | 78.33%-214.34K | -108.90%-2.77K | -277.48%-130.14K |
| Total composite income | 37.36%239.74M | 34.71%177.02M | 40.25%110.6M | 65.95%277.5M | 51.66%174.53M | 15.73%131.41M | 23.32%78.86M | -30.38%167.22M | -15.86%115.08M | -38.87%113.55M |
| Total composite income of parent company owners | 37.34%238.75M | 35.02%176.52M | 40.62%110.61M | 49.06%259.32M | 44.86%173.84M | 11.80%130.74M | 20.51%78.66M | -29.55%173.97M | -15.51%120.01M | -38.20%116.94M |
| Total composite income of minority owners | 43.06%985.42K | -26.57%490.93K | -102.18%-4.49K | 369.12%18.17M | 113.99%688.84K | 119.74%668.53K | 115.56%205.4K | -0.05%-6.75M | 6.38%-4.92M | 2.60%-3.39M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.